Alligator Bioscience Appoints Johan Giléus as New CEO, Søren Bregenholt to Step Down at Year-End

Alligator Bioscience (Nasdaq Stockholm:ATORX), a biotechnology company, announced the appointment of Johan Giléus as its new Chief Executive Officer, effective January 1, 2027. Giléus will also continue in his role as CFO. Current CEO Søren Bregenholt will remain in his position until December 31, 2026. This leadership change follows the company's strategic refocusing towards its financial interest in the HER2-targeting antibody program HLX22.